TECH OUTLOOKTECH OUTLOOKJULY - 20215CXO INSIGHTSCXO INSIGHTSEffective Pharmacovigilance Driven by Infrastructure Integration, Cross-Functional Collaboration and Technological AdvancementAmie Goulbourne, MPH, MT(ASCP), Senior Director, Head of Pharmacovigilance Operations, Compliance and Training, Boston Biomedical, Inc.29Revamping Drug Discovery and Development through Technology InnovationDr. Michelle M. Chen, VP and Head of Corporate Development, WuXi Biologics21How Small Pharma, Working within a Global Pharma, Can Benefit from One Pharmacovigilance SystemMai Huang, M.D., Executive Director, Drug Safety and Pharmacovigilance, Avanir Pharmaceuticals36Revolutionizing Genome Editing with CRISPRMark Behlke, CSO, Integrated DNA Technologies42Why Drug Safety is Ripe for an AI RevolutionJanice Chang, Executive Vice President, TransCelerate BioParma Inc25C O NT E NT SPg 10-11 IN F CUSPg 16 - 4425 TECH OUTLOOKSOLUTION PROVIDERS - 2021TOP 10IMMUNOTHERAPY
< Page 4 | Page 6 >